mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.3 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |